Five years after Medtronic's billion-dollar purchase of HeartWare International, the company discontinued the device at the center of acquisition — a miniaturized, implantable heart pump — with no ...

Medtronic’s HeartWare Ventricular Assist Device (HVAD) may be off the market, but it’s still very much on the company’s mind. The devicemaker discontinued new sales and implants of its HeartWare ...

SALT LAKE CITY- Surgeons at University of Utah Hospital have performed the hospital’s first implant of a new generation left ventricular assist device (LVAD) using the HeartWare HVAD. The tiny, ...

After issuing near-monthly safety warnings related to its discontinued HeartWare Ventricular Assist Device (HVAD) last year, Medtronic is already continuing the trend in 2023. The heart pump’s first ...

As one of two major players in the left ventricular assist device (LVAD) market, HeartWare has been seen as an acquisition target in the past. In fact, LVAD pioneer and HeartWare competitor Thoratec ...

FRAMINGHAM, MA — HeartWare International, the maker of ventricular assist devices (VADs), issued a class I recall of older ventricular assist system controllers [1]. The external controllers, which ...

Medtronic is recalling one lot of batteries that power its HeartWare Ventricular Assist Device (HVAD) System due to a welding defect that can cause them to malfunction. The US Food and Drug ...

WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant. Regulators approved HeartWare’s ...

BOSTON/CHICAGO, Feb 23 (Reuters) - A leading hospital for implanting mechanical heart devices has suspended use of an experimental heart pump made by HeartWare International Inc after a patient ...